Severe Chronic Idiopathic Thrombocytopenic Purpura during Childhood: Definition, Management, and Prognosis

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 6, 2003, Pages 595-603

  Buchanan, George R ^a,b   Journeycake, Janna M ^a   Adix, Leah ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Helen DeVos Children's Hospitalz   (United States)

Author keywords

Chronic; ITP; Severe; Splenectomy; Thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; ASCORBIC ACID; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DANAZOL; DAPSONE; DEXAMETHASONE; FC RECEPTOR; IBUPROFEN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INDIUM 111; MEASLES MUMPS RUBELLA VACCINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT ALPHA INTERFERON; RHESUS D ANTIBODY; RITUXIMAB; THROMBOCYTE ANTIBODY; VINBLASTINE; VINCRISTINE;

BLEEDING; BLOOD CELL COUNT; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SEPTICEMIA; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TOXICITY;

ADRENAL CORTEX HORMONES; CHILD; DISEASE PROGRESSION; HEMORRHAGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PLATELET COUNT; PROGNOSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY;

EID: 0346100478     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815627     Document Type: Review

References (50)

1. Kühne T, Imbach P, Bolton-Maggs PHB, et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 2001;358:2122-2125
2. Robb LG, Tiedeman K. Idiopathic thrombocytopenic purpura: predictors of chronic disease. Arch Dis Child 1990;65:502-506
3. Lowe EJ, Buchanan GR. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. J Pediatr 2003;141:253-258
4. Reid MM. Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child 1995;72:125-128
5. Blanchette VS, Carcao MD. Approach to the investigation and management of immune thrombocytopenic purpura in children. Semin Hematol 2000;37:299-314
6. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008
7. British Committee for Standards in General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-596
8. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40
9. Kühne T, Imbach P. Chronic immune thrombocytopenic purpura in childhood. SeminThromb Hemost 1998;24:549-553
10. Lilleyman JS. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol 1999;105:871-875
11. Walker RW, Walker W. Idiopathic thrombocytopenia, initial illness and long-term follow-up. Arch Dis Child 1984;59:316-322
12. Buchanan GR, Adix L. Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura. Semin Thromb Hemost 2001;27:277-285
13. Lilleyman JS. Definitions and dogma in childhood idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 1993;10:11-14
14. Sutor AH, Grohmann A, Kaufmehl K, Wündisch T. Problems with platelet counting in thrombocytopenia. A rapid manual method to measure low platelet counts. Semin Thromb Hemost 2001;27:237-243
15. Wong MS-C, Chan GC-F, Ha SY, Lau Y-L. Clinical characteristics of chronic idiopathic thrombocytopenia in Chinese children. J Pediatr Hematol Oncol 2002;24:648-652
16. Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002; 141:683-688
17. Medeiros D, Buchanan GR. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood. Pediatr Clin North Am 1996;43:757-772
18. Bolton-Maggs PHB, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997;350:620-623
19. George JN. Initial management of immune thrombocytopenic purpura in children: is supportive counseling without therapeutic intervention sufficient? J Pediatr 2000;137:598-600
20. Carcao MD, Blanchette VS, Stephens D, et al. Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100®). Br J Haematol 2002;117:961-964
21. Crosby WH. Wet purpura, dry purpura. JAMA 1975;232:744-745
22. Godeau B, Chevret S, Varet B, et al, for the French AITP Study Group. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomized, multicentre trial. Lancet 2002;359:23-29
23. Lacey JV, Penner JA. Management of idiopathic thrombocytopenic purpura in the adult. Semin Thromb Hemost 1977;3:160-174
24. Barnard D, Woloski M, Feeny D, et al, for the Canadian Children's Platelet Study Group. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol 2003;25:56-62
25. Bolton-Maggs PHB, Dickerhoff R, Vora AJ. The nontreatment of childhood ITP (or "the art of medicine consists of amusing the patient until nature cures the disease"). Semin Thromb Hemost 2001;27:269-275
26. Dickerhoff R, von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr 2000;137:629-632
27. Buchanan GR. ITP: how much treatment is enough? Contemp Pediatr 2000;17:112-121
28. Lilleyman JS. Intracranial hemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child 1994;71:251-253
29. Miller E, Waight P, Farrington P, et al. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 2001;84:227-229
30. Vlacha V, Forman EN, Miron D, Peter G. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination. Pediatrics 1996;97:738-739
31. Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr 1999;134:21-26
32. Newman GC, Novoa MV, Fodero EM, et al. A dose of 75 μg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpura. Br J Haematol 2001;112:1076-1078
33. Andrew M, Blanchette VS, Adams M, et al. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 1992;120:522-527
34. Bussel JB. Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura. Semin Hematol 2000;37:1-4
35. Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 1994;330:1560-1564
36. Kühne T, Freedman J, Semple JW, et al. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr 1997;130:17-24
37. Chen J-S, Wu J-M, Chen Y-J, Yeh T-F. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 1997;19:526-529
38. Mantadakis E, Buchanan GR. Elective splenectomy in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2000;22:148-153
39. Szold A, Schwartz J, Abu-Abeid S, Bulvik S, Eldor A. Laparoscopic splenectomies for idiopathic thrombocytopenic purpura: experience of sixty cases. Am J Hematol 2000;63:7-10
40. Farah RA, Rogers ZR, Thompson WR, et al. Comparison of laparoscopic and open splenectomy in children with hematologic disorders. J Pediatr 1997;131:41-46
41. Holt D, Brown J, Terrill K, et al. Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura. Pediatrics 2003;111:87-90
42. Law C, Marcaccio M, Tam P, Heddle N, Kelton JG. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 1997;336:1494-1498
43. 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. Br J Haematol 1997;97:547-550
44. Hemmila MR, Foley DS, Castle VP, Hirschl RB. The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin. J Pediatr Surg 2000,35:967-972
45. Williams JA, Boxer LA. Combination therapy for refractory idiopathic thrombocytopenic purpura in adolescents. J Pediatr Hematol Oncol 2003;25:232-235
46. Quiquandon I, Fenaux P, Caulier MT, et al. Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases. Br J Haematol 1990;74:223-228
47. Donato H, Kohan R, Picón A, et al. α-Interferon therapy induces improvement of platelet counts in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2001;233:598-603
48. Hrstková H, Bajer M, Michálek, J. Recombinant human interferon ́ -2a therapy in children with chronic immune thrombocytopenic purpura. J Pediatr Hematol Oncol 2002;24:299-303
49. Stasi R, Pagano A, Stipa EL, Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 2001;98:952-957
50. Zecca M, Nobili B, Ramenghi U, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 2003;101:3857-3861